| LOX-1, OxLDL, and atherosclerosis A Pirillo, GD Norata, AL Catapano Mediators of inflammation 2013, 2013 | 794 | 2013 |
| Global epidemiology of dyslipidaemias A Pirillo, M Casula, E Olmastroni, GD Norata, AL Catapano Nature Reviews Cardiology 18 (10), 689-700, 2021 | 389 | 2021 |
| Berberine, a plant alkaloid with lipid-and glucose-lowering properties: from in vitro evidence to clinical studies A Pirillo, AL Catapano Atherosclerosis 243 (2), 449-461, 2015 | 292 | 2015 |
| Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels N Ferri, G Tibolla, A Pirillo, F Cipollone, A Mezzetti, S Pacia, A Corsini, ... Atherosclerosis 220 (2), 381-386, 2012 | 285 | 2012 |
| Dietary linoleic acid and human health: Focus on cardiovascular and cardiometabolic effects F Marangoni, C Agostoni, C Borghi, AL Catapano, H Cena, A Ghiselli, ... Atherosclerosis 292, 90-98, 2020 | 280 | 2020 |
| HDL in innate and adaptive immunity AL Catapano, A Pirillo, F Bonacina, GD Norata Cardiovascular research 103 (3), 372-383, 2014 | 267 | 2014 |
| HDL in infectious diseases and sepsis A Pirillo, AL Catapano, GD Norata High density lipoproteins: from biological understanding to clinical …, 2015 | 234 | 2015 |
| Emerging role of high density lipoproteins as a player in the immune system GD Norata, A Pirillo, E Ammirati, AL Catapano Atherosclerosis 220 (1), 11-21, 2012 | 208 | 2012 |
| Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells GD Norata, P Marchesi, A Pirillo, P Uboldi, G Chiesa, V Maina, ... Arteriosclerosis, thrombosis, and vascular biology 28 (5), 925-931, 2008 | 194 | 2008 |
| Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice GD Norata, P Marchesi, S Passamonti, A Pirillo, F Violi, AL Catapano Atherosclerosis 191 (2), 265-271, 2007 | 189 | 2007 |
| Apolipoprotein C-III: from pathophysiology to pharmacology GD Norata, S Tsimikas, A Pirillo, AL Catapano Trends in pharmacological sciences 36 (10), 675-687, 2015 | 186 | 2015 |
| Effector memory T cells are associated with atherosclerosis in humans and animal models E Ammirati, D Cianflone, V Vecchio, M Banfi, AC Vermi, M De Metrio, ... Journal of the American Heart Association 1 (1), e000125, 2012 | 182 | 2012 |
| Statin use and risk of new-onset diabetes: A meta-analysis of observational studies M Casula, F Mozzanica, L Scotti, E Tragni, A Pirillo, G Corrao, ... Nutrition, metabolism and cardiovascular diseases 27 (5), 396-406, 2017 | 167 | 2017 |
| High-density lipoprotein subfractions-what the clinicians need to know A Pirillo, GD Norata, AL Catapano Cardiology 124 (2), 116-125, 2013 | 150 | 2013 |
| Postprandial lipemia as a cardiometabolic risk factor A Pirillo, GD Norata, AL Catapano Current medical research and opinion 30 (8), 1489-1503, 2014 | 143 | 2014 |
| Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering GD Norata, H Tavori, A Pirillo, S Fazio, AL Catapano Cardiovascular Research 112 (1), 429-442, 2016 | 140 | 2016 |
| Proteome of endothelial cell‐derived procoagulant microparticles C Banfi, M Brioschi, R Wait, S Begum, E Gianazza, A Pirillo, L Mussoni, ... Proteomics 5 (17), 4443-4455, 2005 | 137 | 2005 |
| Vascular inflammation and low‐density lipoproteins: is cholesterol the link? A lesson from the clinical trials AL Catapano, A Pirillo, GD Norata British journal of pharmacology 174 (22), 3973-3985, 2017 | 129 | 2017 |
| Cholesterol metabolism, pancreatic β-cell function and diabetes C Perego, L Da Dalt, A Pirillo, A Galli, AL Catapano, GD Norata Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1865 (9 …, 2019 | 102 | 2019 |
| Modified HDL: biological and physiopathological consequences GD Norata, A Pirillo, AL Catapano Nutrition, metabolism and cardiovascular diseases 16 (5), 371-386, 2006 | 101 | 2006 |
Catapano A or Catapano ALUniversity of Milan and Multimedica IRCCSVerified email at unimi.it
